Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phathom Pharmaceuticals (PHAT) Amortization of Deferred Charges (2022 - 2026)

Phathom Pharmaceuticals (PHAT) has disclosed Amortization of Deferred Charges for 5 consecutive years, with $844000.0 as the latest value for Q1 2026.

  • For Q1 2026, Amortization of Deferred Charges rose 21.26% year-over-year to $844000.0; the TTM value through Mar 2026 reached $3.2 million, up 30.99%, while the annual FY2025 figure was $3.0 million, 37.5% up from the prior year.
  • Amortization of Deferred Charges hit $844000.0 in Q1 2026 for Phathom Pharmaceuticals, up from -$465000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $2.0 million in Q3 2025 and bottomed at -$465000.0 in Q4 2025.
  • Average Amortization of Deferred Charges over 5 years is $671235.3, with a median of $589000.0 recorded in 2024.
  • On a YoY basis, Amortization of Deferred Charges climbed as much as 247.88% in 2025 and fell as far as 173.93% in 2025.
  • Phathom Pharmaceuticals' Amortization of Deferred Charges stood at $890000.0 in 2022, then crashed by 36.4% to $566000.0 in 2023, then increased by 11.13% to $629000.0 in 2024, then crashed by 173.93% to -$465000.0 in 2025, then soared by 281.51% to $844000.0 in 2026.
  • According to Business Quant data, Amortization of Deferred Charges over the past three periods came in at $844000.0, -$465000.0, and $2.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.